ライフサイエンスコーパス: meconium

1 activating agents, such as serum proteins or meconium.

2 ntegrase inhibitor was achieved in 0.25 g of meconium.

3 , with the notable exception of the neonatal meconium.

4 entrations ranging from 2.0 to 10.0 ng/mL in meconium.

5 n claimed to exist in human tumors and fetal meconium.

6 lung injury caused by instillation of human meconium.

7 as created by tracheal instillation of human meconium.

8 n a rat model of acute lung injury caused by meconium.

9 the window of time available for removal of meconium.

10 rted drug use by the mothers was verified by meconium analysis.

11 etection ranged between 0.2 and 0.7 ng/g for meconium and between 0.3 and 0.7 ng/mL for semen.

12 luid (AF) and exceptionally enriched in both meconium and feces of infants.

13 entrations of phthalate metabolites in human meconium and in semen.

14 first added to the Survanta, then mixed with meconium and instilled into the lungs.

15 lymers reverse inactivation of surfactant by meconium and other substances.

16 used the first feces sample of each patient (meconium), as well as the last 2 feces samples prior to

17 hereas reversible neonatal processes such as meconium aspiration and persistent fetal circulation hav

18 Early institution of HFO at 15 Hz in meconium aspiration may exacerbate air trapping.

19 djRR] 0.33; 95% CI 0.13-0.80, P = 0.015) and meconium aspiration syndrome (0.44% versus 0.86%; adjRR

20 se in other respiratory disorders, including meconium aspiration syndrome and pneumonia.

21 ctively ventilate and oxygenate piglets with meconium aspiration syndrome at lower mean airway pressu

22 Sixty-four of 65 (98.5%) neonates with meconium aspiration syndrome survived.

23 ch as acute respiratory distress syndrome or meconium aspiration syndrome where naturally occurring s

24 scores between 0 and 3 at 5 and 10 minutes, meconium aspiration syndrome, and neonatal seizures, adj

25 and near term infants is usually a result of meconium aspiration syndrome, sepsis, pulmonary hypoplas

26 In this model of meconium aspiration syndrome, short-term exposure to inh

27 ch as acute respiratory distress syndrome or meconium aspiration syndrome.

28 ECMO can potentially eliminate mortality for meconium aspiration syndrome.

29 the optimal method of respiratory support in meconium aspiration syndrome.

30 Meconium aspiration was induced in 30 piglets.

31 tion and Pao2 were significantly lower after meconium aspiration when compared with baseline values.

32 The ORs for Apgar scores 0-3 at 5 minutes, meconium aspiration, and neonatal seizures increased sim

33 applicability was demonstrated by analyzing meconium from HIV-uninfected infants born to HIV-positiv

34 Serum, cholesterol, and meconium have been described as inhibitory agents of sur

35 A variety of substances including human meconium have been found to affect adversely the surface

36 aeruginosa) lung infection, and presence of meconium ileus (MI), has been partially explained by gen

37 segregated into four diagnostic categories: meconium ileus (MI), prenatal/neonatal screening (SCREEN

38 al gland fluid secretion; variably penetrant meconium ileus (MI); pancreatic, liver, and vas deferens

39 nts were ExFM22+, compared with infants with meconium ileus (n = 24; 13% of infants were ExBF >/=1 mo

40 rs for bronchiectasis were presentation with meconium ileus (odds ratio, 3.17; 95% confidence interva

41 family history (FH), and symptoms other than meconium ileus (SYMPTOM).

42 Neonatal intestinal obstruction (meconium ileus [MI]) occurs in 15% of patients with cyst

43 ain polymorphism associated with more severe meconium ileus in cystic fibrosis patients.

44 Whereas meconium ileus occurs in 15% of babies with CF, the pene

45 es identified because of symptoms other than meconium ileus were diagnosed at significantly older age

46 ls with CF (female sex and presentation with meconium ileus).

47 ed with pancreatic insufficiency, history of meconium ileus, and female sex but positively correlated

48 d defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and foc

49 Male sex, pancreatic insufficiency, meconium ileus, histamine blocker use, and respiratory P

50 Excluding infants with meconium ileus, we evaluated nutritional status for up t

51 dder, vas deferens loss, airway disease, and meconium ileus.

52 protein (iFABP) promoter would alleviate the meconium ileus.

53 r hepatic correction is sufficient to rescue meconium ileus.

54 20% of wild-type CFTR mRNA largely prevented meconium ileus.

55 After 1 hr of recovery, 10 mL/kg of 20% meconium in normal saline solution was insufflated into

56 nous catheters were inserted; 5 mL/kg of 20% meconium in normal saline was instilled into the endotra

57 factant inhibition by serum, cholesterol, or meconium in the captive bubble surfactometer.

58 In contrast, in post-meconium, increased numbers of staphylococci were negati

59 iratory pressure at 1, 2, 3, and 4 hrs after meconium instillation (p < .018) and significantly lower

60 ean airway pressure at 2, 3, and 4 hrs after meconium instillation (p < .03).

61 Meconium instillation produced similar stable decreases

62 cocaine and multiple cocaine metabolites in meconium makes this method a powerful tool for the study

63 e up to 4-10% of the total protein amount in meconium, making it one of the most abundant proteins.

64 .038), this was not true for neonatal stool (meconium; Mann-Whitney P > 0.05), and there was no obser

65 osure of native surfactant to cholesterol or meconium, on the other hand, modifies the compressibilit

66 One to 3% human meconium or other inactivating substances were then adde

67 rs were added after mixing of surfactant and meconium or other inhibitors, indicating that polymers a

68 surfactant-inhibitory agents such as serum, meconium, or cholesterol reach the lung.

69 helps in differentiating it from a teratoma, meconium peritonitis and abdominal ectopic pregnancy.

70 The AF, but not the meconium SALSA, bound to Streptococcus pyogenes, S. agal

71 ncrease in lactate-producing bacilli in post-meconium samples (rho = -0.45; P = .004).

72 d breast milk--on spiked samples and on five meconium samples and one pooled semen sample from people

73 , the authors studied maternal histories and meconium samples obtained in November-December 1999 from

74 ously extracted from suspected drug-positive meconium samples using solid-phase extraction.

75 In post-meconium samples, the abundance of staphylococci became

76 sociated gut microbiota can be identified in meconium samples; C. perfringens continues to be associa

77 e minimum surface tension in the presence of meconium, serum, or lysophosphatidylcholine.

78 expectantly managed were more likely to have meconium-stained amniotic fluid than those who were elec

79 ew consent and 15 non-vigorous neonates with meconium-stained amniotic fluid were excluded.

80 Risks of preterm delivery, meconium-stained amniotic fluid, and stillbirth rose wit

81 h a decreased risk for cesarean delivery and meconium-stained amniotic fluid.

82 vent surfactant inhibition by cholesterol or meconium, suggesting that the protective action of polym

83 We postulate that polymers separate meconium-surfactant complexes, permitting surfactant com

84 Substances (for example, serum proteins or meconium) that interfere with the activity of pulmonary

85 ues to be associated with NEC from the first meconium till just before NEC onset.

86 s inherent low tidal volumes, progression of meconium to the distal airways may be delayed.

87 Analytes were extracted from meconium using buffer, concentrated by solid-phase extra

88 iretroviral (ARV) drugs and 4 metabolites in meconium was developed and validated.

89 Extraction efficiencies from meconium were 32.8-119.5% with analytical recovery of 80

90 ngens (8.4%) and Bacteroides dorei (0.9%) in meconium were increased in neonates who developed NEC co